The two Dresden family-owned companies qualitype GmbH and Biotype GmbH are the hosts. Both, together with ROTOP Pharmaka GmbH, are joining forces in the Molecular Diagnostics Group (MDG) competence network. The main goal is the development and marketing of innovative diagnostic solutions for personalised medicine. This results in products and services for medical research and clinical routine as a basis for targeted therapy decisions.

Qualitype GmbH sees itself as a software partner for digital laboratory processes. Numerous state criminal investigation departments, for example, rely on the expertise of the specialists from IT, biology, mathematics, forensics and physics in the field of forensics - from digital case management to expert solutions for DNA analysis. Other areas of focus include the development of laboratory automation solutions, cloud applications for sample management and software development for laboratory equipment and medical devices.

Biotype GmbH is an internationally active medical technology and diagnostics company. With a focus on multiplex PCR and molecular diagnostics, in-vitro diagnostics, kits and systems for clinical research and diagnostics are developed and marketed. The products support the diagnosis and therapy of various types of cancer.